Here, we harnessed the power of RENOIR to develop classifiers predicting the mutation status of TP53 from transcriptomic data, sourced from two well-established databases—the Cancer Cell Line Encyclopedia (CCLE) and The Cancer Genome Atlas. The gene discussed is TP53; the disease is cancer.